Abstract. Hyperoxaluria leads to calcium oxalate (CaOx) crystallization and development of tubulointerstitial lesions in the kidneys. Treatment of hyperoxaluric rats with angiotensin II (Ang II) type I receptor blocker (ARB) reduces lesion formation. Because Ang II mediates osteopontin (OPN) synthesis, which is involved in both macrophage recruitment and CaOx crystallization, it was hypothesized that ARB acts via OPN. Hyperoxaluria was induced in 10-wk-old male Sprague-Dawley rats, and they were treated with ARB candesartan. At the end of 4 wk, kidneys were examined for crystal deposits, ED-1-positive cells, and expression of OPN mRNA. PCR was used to quantify OPN, renin, and angiotensin-converting enzyme (ACE) mRNA in kidneys. RIA was used to determine renal, plasma, and urinary OPN; plasma renin; Ang II and ACE; and renal Ang II. For evaluating oxidative stress, malondialdehyde was measured. Urinary calcium, oxalate, creatinine, and albumin were also determined. Despite similar urinary calcium and oxalate levels, kidneys of hyperoxaluric rats on candesartan had fewer CaOx crystals, fewer ED-1-positive cells, reduced OPN expression, and reduced malondialdehyde than hyperoxaluric rats. Urinary albumin excretion and serum creatinine levels improved significantly on candesartan treatment. mRNA for OPN, renin, and ACE were significantly elevated in hyperoxaluric rats. OPN synthesis and production increased with hyperoxaluria but to a lesser extent in candesartan-treated hyperoxaluric rats. These results show for the first time that oxalate can activate the renal renin-angiotensin system and that oxalate-induced upregulation of OPN is in part mediated via renal renin-angiotensin system.
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Oxalate, a by-product of metabolism, is normally excreted in the urine and at low concentrations is harmless to the renal epithelial cells. However, elevated oxalate levels and/or calcium oxalate (CaOx) crystals are injurious (1) (2) (3) . In addition, exposure of renal epithelial cells in vitro to high levels of oxalate and/or CaOx crystals upregulates the production of chemoattractants osteopontin (OPN) (4) and monocyte-chemoattractant protein-1 (MCP-1) (5, 6) . Mild idiopathic hyperoxaluria is associated with CaOx nephrolithiasis, whereas hyperoxaluria resulting from jejunal bypass for obesity or genetic defects in oxalate metabolism is nephrotoxic and produces tubulointerstitial lesions. Tubulointerstitial damage is recognized as one of the most important risk factors for the development of chronic renal diseases and eventual renal failure (7) .
All components of the renin-angiotensin system (RAS) are produced within the kidney, and intrarenal RAS plays pivotal role in renal disease progression (8) . Kidneys produce both angiotensinogen and angiotensin-converting enzyme (ACE), and juxtaglomerular apparatus is the main source of circulating renin. Renin catalyzes the production of angiotensin I, which is converted to angiotensin II (Ang II) by the actions of ACE. Ang II acts through two receptors, types 1 (AT1) and 2 (AT2), and mediates many effects of the RAS, regulating numerous physiologic reactions including salt and water balance, aldosterone release, and BP (9) . Oxidative stress plays a significant role in proinflammatory effects of Ang II. ACE inhibitors and AT1 receptor blockers have been shown to provide protection against Ang II-induced fibrosis and oxidative stress.
Because RAS plays a significant role in the development of renal tubulointerstitial fibrosis, Toblii et al. (10) investigated its involvement in hyperoxaluria-induced tubulointerstitial lesion. They induced hyperoxaluria in male Sprague-Dawley rats by administering ethylene glycol (EG) and evaluated whether AT1 receptor blockade prevents the development of CaOx deposits in the kidneys. Despite similar oxalate levels, rats that received losartan, AT1 receptor blocker, showed fewer CaOx crystal deposits in the kidneys and fewer ED-1-positive cells in the interstitium. It was concluded that the beneficial effect of losartan is a result of a combination of factors including reduction in crystal formation, control of inflammation, and reduction in oxidative stress. Oxidative stress is a key component of both oxalate-induced and angiotensin-induced renal injury. Toblli et al. (11) obtained similar results when an ACE inhibitor, enalapril, was given to the hyperoxaluric rats. Results of these studies raised a number of questions. Were there any changes in the components of the renal RAS system, and how did these changes affect crystal deposition in the kidneys? Because OPN can modulate various steps of CaOx crystallization (12) (13) (14) (15) (16) (17) (18) and plays a significant role in CaOx crystal deposition in the kidneys in experimental animals (19, 20) and its tissue expression is affected by Ang II (21-23), we hypothesized that Ang II receptor antagonists may in part act through the regulation of OPN production. Therefore, we administered candesartan, an AT1 receptor antagonist (ARB), to rats with EG-induced hyperoxaluria and investigated (1) changes in renal expression of OPN, renin, and ACE mRNA; (2) changes in OPN, renin, ACE, and Ang II in the supernatant of the homogenized kidneys and/or serum and/or urine; (3) change in macrophage influx into the renal interstitium; and (4) change in CaOx crystal deposition in the rat kidneys with and without ARB.
Materials and Methods

Rat Model of Urolithiasis
Hyperoxaluria was induced in 10-wk-old male Sprague-Dawley rats (280 to 300 g) by administering 1.0% EG in drinking water for 4 wk. Four groups of 10 rats each were studied: group A, untreated control animals; group B, hyperoxaluria without treatment; group C, hyperoxaluria with ARB agent candesartan (20 g/ml in drinking water); and group D, ARB (candesartan 20 g/ml). Experimental details on urine collection, kidney removal, and processing have been described previously (19) .
Plasma and supernatant of homogenized kidney tissue samples (whole kidneys were homogenized with 3 vol of cold PBS and centrifuged at 8000 ϫ g for 10 min) were assayed for total protein using the BioRad Protein Assay kit (BioRad Laboratories, Hercules, CA). Renin, Ang II and ACE, and serum and supernatant of homogenized kidney tissue were measured with RIA using SRL kit (SRL, Tokyo, Japan). OPN in supernatant of homogenized kidney tissue samples and in urine was measured with an ELISA kit (IBL, Gumma, Japan) as described previously (24) . We used anti-rat OPN rabbit IgG as capture antibody and streptavidin-peroxide-conjugated anti-OPN IgG as the secondary antibody. Human recombinant OPN was used as the standard. Urine samples were analyzed for calcium, oxalate, and albumin. Serum and urine creatinine and serum blood urea nitrogen were also measured. Calcium concentrations in whole kidneys were measured with an atomic absorption spectrophotometer according to the manufacturer's directions.
Reverse Transcriptase for Real-Time PCR
The mRNA levels of glyceraldehyde-3 phosphate dehydrogenase (GAPDH), OPN, renin, and ACE mRNA in whole kidney was determined using real-time PCR. Total RNA was isolated from kidney using TRI ZOL Reagent (Life Technologies BRL, Grand Island, NY) according to the manufacturer's protocol. Two micrograms of total RNA was reverse-transcribed to cDNA. In brief, 50-l reactions contained 3 l of 100 mM MgCl, 1.25 l of RNase inhibitor, 5 l of 10ϫ PCR buffer, 10 l of 10 mM dNTP mix, 1.3 l of Oligo d(T), and 1.5 l of reverse transcriptase (all from Life Technologies BRL). This mixture was incubated 60 min at 37°C, and then reaction mixture was heated to 94°C for 5 min to stop the reaction.
Primers for Real-Time PCR
Primers were designed using Primer Express software (PE Applied Biosystems, Foster City, CA) as follows: GAPDH (accession no. NM_017008), 5'-TGCCAAGTATGATGACATCAAGAA-3' (forward primer, bases 780 to 803) and 5'-AGCCCAGGATGCCCTTTAGT-3' (reverse primer, bases 831 to 850); OPN (accession no. NM_012881), 5'-TGAGACTGGCAGTGGTTTGC-3' (forward primer, bases 81 to 100) and 5'-CCACTTTCACCGGGAGACA-3' (reverse primer, bases 125 to 143); renin (accession no. NM_012642), 5'-ACCAG-GGCAACTTTCACTACGT-3' (forward primer, bases 740 to 761) and 5'-ACCCCCTTCATGGTGATCTG-3' (reverse primer, bases 787 to 806); ACE (accession no. NM_012544), 5'-TTGTCTGTCACTGGAGC-CTGAT-3' (forward primer, bases 2327 to 2348) and 5'-CACAC-CCAAAGCAATTCTTCGT-3' (reverse primer, bases 2380 to 2401).
Real-Time Quantitative PCR
PCR product was directly monitored by measuring the increase in fluorescence of dye (SYBR GREEN; PE Applied Biosystems) bound to the amplified double-stranded DNA. The parameter of threshold cycle (C T ) was defined as the fractional cycle number at which fluorescence exceeds a threshold level. The comparative C T method quantifies the amount of mRNA relative to that of a reference sample, termed the calibrator, for comparison of the expression level of every unknown sample. For normalizing the relative amount of MCP-1 mRNA, GAPDH mRNA was chosen as an internal reference. The changes in expression are given by unknown samples of interest.
All PCR reactions were performed using an ABI Prism 7700 Sequence Detection System (PE Applied Biosystems). For each PCR run, a master mix was prepared: 1ϫ SYBR PCR buffer; 3 mM MgCl 2 ; 200 M dATP, dCTP, and dGTP; 400 M dUTP; 300 M primer set for MCP-1 and GAPDH; and 1.25 units of AmpliTaq Gold DNA polymerase. Five milliliters of diluted (1:20) cDNA was added to 45 l of the PCR master mix. After an initial 10-min denaturation at 95°C, the thermal cycling comprised 40 cycles of denaturation at 95°C for 15 s and annealing and extension at 60°C for 1 min.
Morphologic Studies
Paraffin-embedded sections (4 m thick) were stained with hematoxylin and eosin to count crystal deposits. Sections were stained with VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions for immunohistochemistry of OPN (ϫ1000 primary antibody: rabbit anti-human OPN polyclonal antibody; IBL, Gumma, Japan) or ED-1 (ϫ500 primary antibody: mouse anti-rat monocytes/macrophage monoclonal antibody; Serotec, Oxford, UK). The number of crystal deposits (% in total tubules) in renal tubules and ED-1-positive cells in the renal interstitium were determined by assessing randomly selected 20 fields per kidney (ϫ200).
Detection of OPN mRNA by In Situ Hybridization
In situ hybridization to detect OPN mRNA expression was performed and analyzed as described in detail previously (19) .
Renal Content of Malondialdehyde
Determination of renal content of malondialdehyde (MDA) was done in supernatants of kidney slices as previously described (24) .
case of a single comparison. For multiple comparisons, Sheffe post hoc test was used only when one-way factorial ANOVA showed a significant difference at P Ͻ 0.05.
Results
There were no significant differences in body weight and volume of drinking water (Table 1) among the four groups. Rate of creatinine clearance was lower in hyperoxaluric rats of group B compared with the normal rats of group A. The clearance rate, however, improved significantly when hyperoxaluric rats were given candesartan as seen in group C rats.
As expected, there was a marked increase in urinary excretion of oxalate by rats in groups B and C (Table 2 ). However, there were no significant differences in urinary excretion of calcium. Whereas candesartan-treated animals in group C showed a high level of oxalate excretion similar to group B, group C rats showed significantly lower amount of albumin in their urine (Table 2) . Table 2 shows urinary concentrations of Ang II; albumin; OPN; and serum concentrations Ang II, OPN, renin, and ACE. Urinary and serum Ang II were significantly higher in groups C and D, which received candesartan. Significant elevation in urinary and serum OPN were observed in hyperoxaluric rats of group B compared with normal rats in group A. Both urinary and serum OPN were significantly reduced on candesartan treatment in group C. Serum renin was significantly increased in rats in groups B, C, and D compared with normal controls of group A. There were no significant differences in serum ACE levels between the various groups.
Hyperoxaluric rats had CaOx crystal deposits in both the cortex and the medulla (Figure 1 ). Crystals were seen in the tubular lumens. Crystal-containing tubules appeared dilated. There was a significant increase in both the calcium contents and the number of crystal deposits in hyperoxaluric rats of groups B and C as compared with the nonhyperoxaluric rats in groups A and D (Table 3) . However, hyperoxaluric rats in group C, which received candesartan treatment, had significantly lower calcium and crystal deposits than the hyperoxaluric rats of group B, which did not receive the candesartan treatment. There was a significant increase in the number of ED-1-positive cells in the renal interstitium of hyperoxaluric rats ( Figure 2 ) in groups B and C. However, candesartantreated rats in group C had significantly fewer ED-1-positive infiltrates compared with rats in the group B (Figure 2 , Table  3) . Table 3 shows renal Ang II, OPN, and MDA levels after 4 wk of experimentation. Hyperoxaluric rats of groups B and C had significantly high levels of renal MDA, a marker of oxidative stress, which went down significantly when candesartan was provided. Levels of Ang II in the kidneys increased with hyperoxaluria in group B and nearly doubled in the candesartan-treated rats of groups C and D. Renal OPN increased in the hyperoxaluric rats of both groups B and C. Candesartan treatment of hyperoxaluric rats in group C resulted in a significant reduction in renal OPN compared with rats in group B, which did not receive the treatment.
Morphologic examination of OPN synthesis and production in kidneys by in situ hybridization (Figure 3 ) and immunohistochemistry (not illustrated) showed that in normal rats, expression was scanty and limited to a few cells of the loops of Henle and surface epithelium of the renal papillae in the renal calyces (not illustrated). Renal papillary tubules of normal control rats, however, were completely devoid of OPN expression. After 4 wk of treatment, however, there was the expected increase in the frequency and intensity of expression in the epithelial cells. The expression was much more prominent and spread throughout the whole kidney, including the epithelial cells lining the tubules of the inner medulla and the renal papillae (Table 4) .
We quantified the increase in GAPDH, OPN, ACE, and renin mRNA using real-time PCR. The standard and amplification curves for GADPH, ACE, OPN, and renin indicated that assays were done in optimum conditions. Figure 4 shows calculated relative quantities of ACE, OPN, and renin mRNA. There were no significant differences in ACE mRNA between various groups. There was, however, significant upregulation of both the OPN and renin mRNA in the hyperoxaluric rats of groups B and C. Candesartan treatment was associated with significant reduction in OPN mRNA in the hyperoxaluric rats of group C but not to the levels of normal rats of group A (Figure 4 ).
Discussion
Both tissue culture and animal model studies have provided evidence that renal epithelial cells are injured in the presence of high levels of oxalate and CaOx crystals (1-3). Injury is mediated by the production of reactive oxygen species causing lipid peroxidation of the cellular membranes (3, 25, 26) . Renal tubular insult is a known cause of glomerular injury and hyperfiltration resulting in enhanced transglomerular protein traffic and proteinuria (27) . In our experiments, hyperoxaluric rats had lower creatinine clearance than normal control rats and hyperoxaluric rats on candesartan. In addition, there was a significant reduction in albumin excretion by hyperoxaluric rats that received candesartan. Earlier studies have also demonstrated a reduction in albumin excretion by hyperoxaluric rats that received the ACE inhibitor losartan (10) or the AT1 receptor blocker enalapril (11) . Similarly, correlation of urinary albumin excretion with the tubulointerstitial fibrosis was also reported (27, 28) . In proteinuric rats, both ACE and angiotensin are upregulated and AT1 receptor is activated.
Results show a significant increase in the expression of renin mRNA in the kidneys and a significant increase in renin levels in the serum of the hyperoxaluric rats. Even though an increase in renin expression in kidneys has been reported in a number of experimental models, this is the first report of elevated renin expression in response to oxaluria and CaOx crystal deposition. This expression may reflect a nonspecific response to renal injury because administration of EG is known to generate a number of metabolites that can be toxic to the kidneys (29) . Increased renin production upregulates the production of angiotensin. The activation of the proximal tubular RAS in streptozotocin-induced diabetic rat is mediated by enhanced expression of renin mRNA. An increase in local production of Ang II Figure 1 . Section of a kidney from the rat in group B, which received only ethylene glycol (EG) for 4 wk. Note calcium oxalate (CaOx) crystals (*) in the tubular lumen. H&E staining, reduced from ϫ200. is suggested to contribute to tubulointerstitial injury in this diabetes model (30) . In addition, RAS is implicated in the pathogenesis of diabetic nephropathy, because of the ability of ACE inhibitors or ARB to diminish proteinuria and retard progressive glomerulosclerosis (31, 32) . Changes in renal renin expression have been seen in salt depletion and ACE inhibition (33, 34) . In the renal tubules of rats with subtotal nephrectomy, expression of renin and Ang II mRNA increased in association with overexpression of TGF-␤ (35). Ang II is a known mediator of TGF-␤ production in a variety of cell types, including proximal tubular cells, renal interstitial fibroblasts, and mesangial and vascular smooth muscle cells. It is interesting that Toblli et al. (10, 11) found increased expression of TGF-␤ in kidneys of hyperoxaluric rats. AT1 receptor blockage downregulated OPN synthesis and production, suggesting an involvement of the RAS system in hyperoxaluria-induced OPN upregulation. Involvement of Ang II in renal OPN expression has been suggested by many studies. Dramatic increase in OPN protein and mRNA levels was observed in renal epithelial cells of the distal tubules and collecting ducts on Ang II infusion (22) . Proximal tubular cells subjected to mechanical stretch exhibited increased mRNA expression. Significant reduction in OPN expression was found after transfection with angiotensinogen or AT1 antisense oligonucleotide (23) . Ang II may stimulate the OPN expression in renal tubules either directly (36) or through induction of TGF-␤ (37).
Candesartan treatment resulted in reduced CaOx crystal deposition and infiltration of ED-1-positive inflammatory cells into renal interstitium. OPN is most likely involved in both events. Free OPN in the solution inhibits the heterogeneous nucleation (16), growth (14, 15) , and aggregation of CaOx crystals (17) . OPN modulates the adhesion of CaOx monohydrate crystals to renal epithelial cells, a mechanism considered critical for crystal retention within the kidneys. Previous exposure of crystals but not cells to OPN blocked the adhesion (18) . However, crystal exposure to urine had no effect on crystal adherence to confluent LLC-PK1 or regenerating MDCK cells (38) . Because candesartan treatment also resulted in reduced OPN production, its crystallization inhibitory activity may not be operative in this model. It has been suggested, however, that surface-immobilized OPN promotes crystal adhesion. Even though OPN is a secreted and soluble protein, it can be immobilized by cross-linking to the extracellular matrix. A prominent coat of OPN is seen on luminal surfaces of specific populations of epithelial cells of gall bladder and urinary tract (39), where it is bound to integrin receptors via arginine-glycine-aspartate cell-binding domains. In normal kidneys, this layer is only faintly visible and restricted to only specific locations (5, 6, 19) , but in hyperoxaluric rats, this layer becomes very conspicuous and CaOx crystals are universally found associated with OPN (19) . Pretreatment of MDCK cells with polyclonal antibodies against OPN inhibited the adhesion of CaOx crystals (40, 41) . Similarly, transfection of NRK52E cells with antisense OPN cDNA significantly reduced adhesion of CaOx crystals to the transfected cell (41) . OPN immobilized on surface of collagen granules promoted CaOx crystal adhesion in vitro (24) . On the basis of the results presented here, we conclude that blockage of AT1 receptor reduced the synthesis and production of OPN and its presence on luminal cell surfaces in the renal tubules, inhibiting crystal adherence, and deposition in the kidneys. Contrary to our results in which reduction in OPN production is associated with decline in crystal retention, results of a recent study using OPN knockout mice demonstrated lack of OPN causing crystal retention in the kidneys after EG administration (20) . These differences may reflect a species-specific reaction to EG and its processing and perhaps crystallization of calcium oxalate. Administration of 1% EG to rats induces copious CaOx crystal deposition (personal observations, S.R. Khan) in the kidneys. However, there was no deposition in wild-type mice and limited deposition in OPN knockout mice. In addition, CaOx crystal deposition in the rats is associated with apoptosis (42), whereas no significant difference in apoptosis was seen between wild-type and OPN knockout mice. Moreover, administration of only 0.75% EG to rats resulted in not only increased synthesis, production, and excretion of OPN but also CaOx crystal deposition (19) .
Reduced synthesis and production of OPN by candesartantreated rats may be partially responsible for reduced infiltration of inflammatory cells into the renal interstitium. OPN is a chemoattractant for many cell types. OPN promotes migration of both T cells and macrophages in vitro in a dose-dependent manner (43, 44) . Elevated OPN gene and protein expression occurs early and precedes the infiltration of monocytes/macrophages (45, 46) . Notable inhibition of glomerular and tubulointerstitial accumulation of macrophages is seen in a rat model of crescentic glomerular basement membrane nephritis after administration of anti-OPN antibody (47) . Because macrophages may be injurious to tubular epithelial cells, they should exhibit an increased level of injury in untreated rats. CaOx crystal deposition in rat kidneys is almost always associated with renal epithelial injury (1, 48), apoptosis (42), and necrosis. Injured epithelium has long been considered receptive to crystal adherence because injuries to the renal epithelial cell surfaces cause an exposure of crystal-binding molecules, including phosphatidylserine (49), hyaluronan and its ligands CD44, and OPN (50) .
There is increasing evidence of a possible link between the RAS, in particular Ang II, and OPN expression and macrophage accumulation. Ang II infusion stimulates expression of OPN, macrophage infiltration, and tubulointerstitial injury (44) . Blockade of the RAS by using either an ACE inhibitor or an ARB reduces tubulointerstitial injury. Furthermore, AT1 receptor activation on proximal tubular cells leads to OPN overexpression, provoking the migration of macrophages and induction of tubulointerstitial injury (23) . Subtotal nephrectomy is associated with substantial upregulation of OPN expression, macrophage accumulation, and severe proteinuria (51) . In a transgenic rat model of diabetic nephropathy characterized by increased synthesis and production of OPN and extensive macrophage accumulation, administration of ACE inhibitor reduced both expression of OPN and buildup of macrophages (52) . In our model, accumulation of ED-1-positive cells may additionally be mediated by MCP-1. We reported earlier that MCP-1 mRNA and protein synthesis are elevated in NRK 52E cells on exposure to oxalate ions or CaOx monohydrate crystals (5, 6) . Glomerular macrophage recruitment in experimental diabetes is largely determined by angiotensin-stimulated MCP-1 expression as well as OPN (53) . AT1 receptor mediates the induction of MCP-1 and macrophage infiltration in hypertensive nephrosclerosis (54) .
Ang II is implicated in causing oxidative stress by stimulating membrane-bound NADH/NADPH oxidase, which leads to increased generation of superoxide (55) (56) (57) . Ang II administration via osmotic pumps increased kidney contents of thiobarbituric acid reactive substances and upregulated heme oxygenase-1, a redox-sensitive enzyme (58) . NADH/NADPH oxidase and p42/44 mitogen-activated protein kinase signaling pathways are involved in the regulation of Ang II-stimulated OPN expression in cardiac microvascular endothelial cells (21) . Patients with hypertension show significantly higher MDA and lower superoxide dismutase. ACE inhibitors and ARB ameliorate these conditions (59) . AT1 receptor blockage in patients with progressive chronic kidney disease and type 2 diabetes or glomerulonephritis results in reduced urinary excretion of MCP-1 and MDA (60) .
In summary, we confirm earlier results of RAS involvement in hyperoxaluria and CaOx crystal-induced renal inflammation. In addition, we provide the evidence that hyperoxaluria and CaOx crystal deposition induce renin synthesis activating the RAS system. Ang II upregulates the synthesis and production of OPN, which coats the luminal surfaces of renal tubular epithelium causing crystal adherence. Blockage of the AT1 receptor reduces OPN production and crystal adherence, thereby reducing crystal deposition within the kidneys ( Figure  5 ). We believe that the findings presented here have clinical and therapeutic significance. Interruption of RAS by either AT1 receptor blocking or inhibition of ACE may reduce renal crystal burden in patients with primary hyperoxaluria.
